Liposomal amphotericin B associated with severe hyperphosphatemia

Scott M. Sutherland; David K. Hong; Jay Balagtas; Kathleen Gutierrez; Christopher C. Dvorak; Minnie Sarwal

doi:10.1097/INF.0b013e31815922a3

Liposomal amphotericin B associated with severe hyperphosphatemia

Scott M. Sutherland, David K. Hong, Jay Balagtas, Kathleen Gutierrez, Christopher C. Dvorak, Minnie Sarwal

Research output: Contribution to journal › Article

10 Scopus citations

Abstract

We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.

Original language	English (US)
Pages (from-to)	77-79
Number of pages	3
Journal	Pediatric Infectious Disease Journal
Volume	27
Issue number	1
DOIs	https://doi.org/10.1097/INF.0b013e31815922a3
State	Published - Jan 2008
Externally published	Yes

Keywords

Amphotericin B
Antifungal
Hyperphosphatemia
Invasive fungal infection

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Microbiology (medical)

Access to Document

10.1097/INF.0b013e31815922a3

Fingerprint Dive into the research topics of 'Liposomal amphotericin B associated with severe hyperphosphatemia'. Together they form a unique fingerprint.

Cite this

Sutherland, S. M., Hong, D. K., Balagtas, J., Gutierrez, K., Dvorak, C. C., & Sarwal, M. (2008). Liposomal amphotericin B associated with severe hyperphosphatemia. Pediatric Infectious Disease Journal, 27(1), 77-79. https://doi.org/10.1097/INF.0b013e31815922a3

@article{4252fa0f941f48039a567b06677669c0,

title = "Liposomal amphotericin B associated with severe hyperphosphatemia",

abstract = "We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.",

keywords = "Amphotericin B, Antifungal, Hyperphosphatemia, Invasive fungal infection",

author = "Sutherland, {Scott M.} and Hong, {David K.} and Jay Balagtas and Kathleen Gutierrez and Dvorak, {Christopher C.} and Minnie Sarwal",

year = "2008",

month = jan,

doi = "10.1097/INF.0b013e31815922a3",

language = "English (US)",

volume = "27",

pages = "77--79",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Liposomal amphotericin B associated with severe hyperphosphatemia

AU - Sutherland, Scott M.

AU - Hong, David K.

AU - Balagtas, Jay

AU - Gutierrez, Kathleen

AU - Dvorak, Christopher C.

AU - Sarwal, Minnie

PY - 2008/1

Y1 - 2008/1

N2 - We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.

AB - We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.

KW - Amphotericin B

KW - Antifungal

KW - Hyperphosphatemia

KW - Invasive fungal infection

UR - http://www.scopus.com/inward/record.url?scp=37549009949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549009949&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e31815922a3

DO - 10.1097/INF.0b013e31815922a3

M3 - Article

C2 - 18162947

AN - SCOPUS:37549009949

VL - 27

SP - 77

EP - 79

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 1

ER -